Clinical trialsCompany release

Quantum BioPharma reports Q3 equity up 91% as Lucid-MS Phase 2 start-up advances

Quantum Biopharma Ltd. (QNTM) · Fri 13 Nov 2026

The company signed a start-up agreement with Thermo Fisher Scientific's clinical research business for a Phase 2 progressive MS trial, after FDA cleared its IND in August.

Quantum BioPharma published unaudited third-quarter 2026 results on 13 November, reporting cash and digital assets of about US$12.22m. Shareholders' equity rose 91% to US$9.77m, while operating expenses for the first nine months of the year fell 32%.

On the development side, the FDA cleared the company's investigational new drug (IND) application for Lucid-MS in August 2026. On 6 October, Quantum signed a Study Start-Up Agreement with Thermo Fisher Scientific's clinical research business to prepare a randomised, placebo-controlled Phase 2 trial in progressive multiple sclerosis.

Outside its core programme, Quantum also extended its loan to Unbuzzd and bought additional shares in that company's private placement. The summary provided does not give the terms or size of either transaction.

An IND clearance allows a sponsor to begin clinical studies in the US; start-up agreements typically cover preparatory work such as site and study set-up. The source does not state a trial start date, enrolment target or timelines.

What it means for your team

  • Lucid-MS now has an FDA-cleared IND and a contracted CRO start-up partner, moving it towards a Phase 2 trial in progressive MS.
  • Teams tracking MS pipelines should note the design: randomised and placebo-controlled; no enrolment size, endpoints or start date were disclosed.
  • The Unbuzzd loan extension and share purchase are separate from the Lucid-MS programme; details of their terms were not provided.

Company's press release (SEC filing): Quantum Biopharma Ltd. ↗

Article written by VigiEye from the official source (Quantum Biopharma Ltd.). Claims are the company's own. AI-assisted; check the source before acting.

More Clinical trials All →